Based on the chemical reaction, Masuda et al. (1), Birch (2), and Rowan et al. (3) proposed that 6-methyl-7-hydroxy-8-ribityllumazine (V compound) arises from the condensation of 4-ribitylamino-5-amino-uracil and pyruvate in vivo. However, this possibility seems to be excluded by Schmeltz and Plaut's recent preliminary work (4) that pyruvate-1-C14 was not incorporated in the methyl group and the carbons 6 and 7 of V compound by Ashbya gossypii.The present authors (5) demonstrated that pyruvate inhibited the conversion of 6, 7-dimethyl-8-ribityllumazine (G compound) into V compound. These observations seem to exclude the possibilities of the re placement of diacetyl moiety of pyrazine ring of G compound by pyruvate, followed by the condensation of 4-ribitylamino-5-aminouracil and pyruvate. The evidence, in the experiments using enzyme preparations from various microorganisms and plants, that V compound derived directly from G compound, has been accumulated (5-8). The non-enzymatic formation of V compound from G compound by aeration or addition of H2O2 was reported by Korte et al. (9,10), from which the loss of the methyl group in the position 7 and its replacement by a hydroxy group is possibly an oxidative or a peroxidative process (4).Although none of these chemical reactions can explain satisfactorily the biolo gical features of the conversion reaction, the chemical reaction, proceeding readily under the physiological conditions used, could be worthy of futher investigations from the biological side.In the present investigations, the authors found the non-enzymatic production of V compound through a new organic reaction of G compound with p-quinone under the physiological conditions. This reaction was explored in detail by using chemical kinetics.